Загрузка...
VP 16-213 in acute myelogenous leukaemia
The use of the epipodophyllotoxin VP 16-213 is described in twenty patients with acute myelogenous leukaemia resistant to other chemotherapy. The drug was usually given in 5-day courses of 50 mg/m(2) daily and occasionally in 24-hr infusions of 250 mg/m(2), on the basis of its phase-activity. Comple...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1976
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2496302/ https://ncbi.nlm.nih.gov/pubmed/772645 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|